Organon & Co. (OGN)
NYSE
Closed
Aug 24, 2026
Day's Range
13.7252 wk Range
5.69Overview - OGN - Organon & Co.
Key Statistics
Valuation
Enterprise Value
11.03B
P/E (Trailing)
‪17.62‬
P/E (Forward)
‪3.80‬
PEG Ratio
‪-0.65‬
Price / Sales (TTM)
‪0.58‬
Price / Book
‪3.58‬
EV / EBITDA
‪7.05‬
Profitability
Gross Margin
‪54.36%‬
Profit Margin
‪3.41%‬
Operating Margin
‪20.73%‬
Return on Assets
‪5.66%‬
Return on Equity
‪24.03%‬
Ownership
Shares Outstanding
262.60M
Float
242.98M
Short % of Shares Outstanding
‪7.28%‬
Held by Insiders
‪0.46%‬
Held by Institutions
‪84.05%‬
Price stats
Beta
‪1.52‬
50-Day Avg
‪13.54‬
200-Day Avg
‪9.96‬
Dividends
Payout Ratio
‪10.26%‬
Frequency
Quarterly
Analyst Consensus
5 analysts
Average price target
‪$ 11.25‬Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - OGN - Organon & Co.
Peers - OGN - Organon & Co.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on NYSE.
- OGNNYSEOrganon & Co.3.61BMarket Cap+34.11%52-week change17.62P/E (Trailing)‪3.41%‬Profit Margin
- LLYNYSEEli Lilly and Company1.11TMarket Cap+44.61%52-week change42.20P/E (Trailing)‪33.52%‬Profit Margin
- JNJNYSEJohnson & Johnson651.25BMarket Cap+33.98%52-week change31.35P/E (Trailing)‪21.48%‬Profit Margin
- ABBVNYSEAbbVie Inc.468.21BMarket Cap+21.67%52-week change74.64P/E (Trailing)‪9.80%‬Profit Margin
- MRKNYSEMerck & Co., Inc.376.36BMarket Cap+43.05%52-week change122.04P/E (Trailing)‪4.76%‬Profit Margin
- NVSNYSENovartis AG Sponsored ADR301.94BMarket Cap+21.29%52-week change24.00P/E (Trailing)‪22.50%‬Profit Margin
- SANNYSEBanco Santander S.A. Sponsored ADR212.65BMarket Cap+34.20%52-week change14.17P/E (Trailing)‪33.46%‬Profit Margin
Profile Summary - OGN - Organon & Co.
About
Organon & Co. is a science-based global pharmaceutical company that develops and delivers innovative health solutions through a portfolio of prescription therapies. Its primary focus areas include women’s health, biosimilars, and established brands, addressing key therapeutic needs in reproductive health, dermatology,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
